972 filings
Page 8 of 49
3
pu5dby9q522 kui
21 Jan 22
Acer Therapeutics / Bernard H Paul ownership change
4:04pm
4
8zs94p9nkwt
19 Jan 22
Acer Therapeutics / Matthew Seibt ownership change
4:32pm
4
b5p18s6
19 Jan 22
Acer Therapeutics / Chris Schelling ownership change
4:29pm
4
akn19mmvnzbzl7f0
19 Jan 22
Acer Therapeutics / HARRY S PALMIN ownership change
4:28pm
4
zzal2d36v00s
19 Jan 22
Acer Therapeutics / John Michael Klopp ownership change
4:25pm
4
oh9kpeenm9hn d27u
19 Jan 22
Acer Therapeutics / Donald Joseph ownership change
4:24pm
4
cevhp8awwy9erg
19 Jan 22
Acer Therapeutics / MICHELLE RENEE GRIFFIN ownership change
4:22pm
4
cktahilo7tex9oicpa
19 Jan 22
Acer Therapeutics / JOHN MICHAEL DUNN ownership change
4:20pm
4
ivjr85pw2alg807k
19 Jan 22
Acer Therapeutics / Jefferson E Davis ownership change
4:18pm
4
mfdjvxd 5828b
19 Jan 22
Acer Therapeutics / STEVE ASELAGE ownership change
4:15pm
4
v3jlg23uin pncwf
19 Jan 22
Acer Therapeutics / Jason Amello ownership change
4:10pm
8-K
34atcel0bsl5 qd
30 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
gurq qbtr106ke4zp
14 Dec 21
Other Events
4:06pm
424B2
rwkl6sa
14 Dec 21
Prospectus for primary offering
4:02pm
4
xn32wegj70 b8s7pu6
13 Dec 21
Acer Therapeutics / STEVE ASELAGE ownership change
4:02pm
8-K
yv1b1rwi83qk72a05g
9 Dec 21
Acer Therapeutics Announces ACER-801 IND Clearance for the Treatment of Induced Vasomotor Symptoms
9:00am
EFFECT
9uzkfs ue
8 Dec 21
Notice of effectiveness
12:15am
CORRESP
8etl6i
3 Dec 21
Correspondence with SEC
12:00am
UPLOAD
he41v4k6bdv
1 Dec 21
Letter from SEC
12:00am